Literature DB >> 24900557

Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders: Patent Highlight.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2012        PMID: 24900557      PMCID: PMC4027450          DOI: 10.1021/ml300405d

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  The 2010 patent landscape for spleen tyrosine kinase inhibitors.

Authors:  Alessandro F Moretto; Christoph Dehnhardt; Neelu Kaila; Nikolaos Papaioannou; Atli Thorarensen
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2012-05

Review 2.  Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders.

Authors:  Tadeusz Robak; Ewa Robak
Journal:  Expert Opin Investig Drugs       Date:  2012-05-22       Impact factor: 6.206

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.